Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 9, 2013)
-
Business Wire (May 7, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 26, 2013)
-
Business Wire (Apr 8, 2013)
-
-
-
-
-
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 7, 2013)
-
Business Wire (Feb 28, 2013)
-
Business Wire (Feb 25, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
Anacor Pharma Poised For Rebound Ahead Of Phase III ResultsMike Havrilla • Mon, Nov 19, 2012 -
-
Anacor Pharma IPO: A Play on Skin CareSA Editor Mohit Manghnani • Fri, Dec 3, 2010
-
-
-
-
-
-
-
-
-
-
-
GM IPO Frenzy Fails to Ignite Biotech OfferingsThe Burrill Report • Fri, Nov 26, 2010 -
4 IPOs on Tap for This WeekRenaissance Capital IPO Research • Mon, Nov 22, 2010 -
-
-
-
-
Business Wire (May 9, 2013)
-
Business Wire (May 7, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 26, 2013)
-
Business Wire (Apr 8, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 7, 2013)
-
Business Wire (Feb 28, 2013)
-
Business Wire (Feb 25, 2013)
-
at MarketWatch.com (Jan 29, 2013)
-
Business Wire (Jan 17, 2013)
-
Business Wire (Dec 10, 2012)
-
Business Wire (Nov 13, 2012)
-
Business Wire (Nov 7, 2012)
ANAC vs. ETF Alternatives
Company Description
Currently, there's no company description for ANAC.
